TITAN PHARM.(DEL) DL-,001

TITAN PHARM.(DEL) DL-,001

Share · US8883147055 · TTNP · A400D1 (XNCM)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of TITAN PHARM.(DEL) DL-,001
Analyst Grade Summary
gauge-img
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
2
2
0
0
No Price
Share Float & Liquidity
Free Float 61,91 %
Shares Float 823.521,00
Shares Outstanding 1,33 M
Company Profile for TITAN PHARM.(DEL) DL-,001 Share
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the European Union. It is also developing kappa opioid agonist peptide program (TP-2021) for use in combination with ProNeura technology for the treatment of chronic pruritus; nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder; and other programs, including HIV preventative therapeutic and a contraceptive from a single ProNeura implant for women and adolescent girls. The company was incorporated in 1992 and is based in South San Francisco, California.

Company Data

Name TITAN PHARM.(DEL) DL-,001
Company Titan Pharmaceuticals, Inc.
Symbol TTNP
Website https://www.titanpharm.com
Primary Exchange XNCM Frankfurt
WKN A400D1
ISIN US8883147055
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Weei Jye Chay
Country United States of America
Currency EUR
Employees 0,0 T
Address 400 Oyster Point Boulevard, 94080-1958 New York City
IPO Date 1996-01-18
Dividends from 'TITAN PHARM.(DEL) DL-,001'
Ex-Date Dividend per Share
17.02.2012 0,01 USD
04.02.2004 0,25 USD

Stock Splits

Date Split
09.01.2024 1:20
01.12.2020 1:30
25.01.2019 1:6
29.09.2015 1:5.5
07.02.2005 1:1000

ID Changes

Date From To
25.11.2008 TTP TTNP

Ticker Symbols

Name Symbol
NASDAQ TTNP
More Shares
Investors who hold TITAN PHARM.(DEL) DL-,001 also have the following shares in their portfolio:
GLOBAL PARTNER ACQUISITION CORPII - UNIT
GLOBAL PARTNER ACQUISITION CORPII - UNIT Share
Smart Closet Inc.
Smart Closet Inc. Share